Sigyn Therapeutics Inc (SIGY)
5.25
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Sigyn Therapeutics Total Assets (Quarterly): 0.3218M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.3218M |
| September 30, 2023 | 0.3872M |
| June 30, 2023 | 0.3618M |
| March 31, 2023 | 0.6604M |
| December 31, 2022 | 0.3329M |
| September 30, 2022 | 0.3623M |
| June 30, 2022 | 0.3959M |
| March 31, 2022 | 0.4474M |
| December 31, 2021 | 0.7103M |
| September 30, 2021 | 1.441M |
| June 30, 2021 | 1.993M |
| March 31, 2021 | 0.609M |
| December 31, 2020 | 0.6941M |
| September 30, 2020 | 0.6102M |
| June 30, 2020 | 0.6227M |
| March 31, 2020 | 0.6336M |
| December 31, 2019 | 0.6421M |
| September 30, 2019 | 0.7632M |
| Date | Value |
|---|---|
| June 30, 2019 | 0.7988M |
| March 31, 2019 | 0.826M |
| December 31, 2018 | 0.862M |
| September 30, 2018 | 1.867M |
| June 30, 2018 | 1.933M |
| March 31, 2018 | 2.045M |
| December 31, 2017 | 2.071M |
| September 30, 2017 | 2.128M |
| June 30, 2017 | 2.227M |
| March 31, 2017 | 2.204M |
| December 31, 2016 | 2.342M |
| September 30, 2016 | 1.058M |
| June 30, 2016 | 1.158M |
| March 31, 2016 | 1.294M |
| December 31, 2015 | 0.2452M |
| September 30, 2015 | 0.8809M |
| December 31, 2014 | 0.5623M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.3218M
Minimum
Dec 2023
1.993M
Maximum
Jun 2021
0.673M
Average
0.6227M
Median
Jun 2020
Total Assets (Quarterly) Benchmarks
| CEL-SCI Corp | 30.05M |
| AIM ImmunoTech Inc | 19.38M |
| IGC Pharma Inc | 11.26M |
| NovaBay Pharmaceuticals Inc | 5.357M |
| Protalix BioTherapeutics Inc | 89.82M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.734M |
| Shareholders Equity (Quarterly) | -3.412M |